Related Experiment Videos
Distribution of transforming growth factor-beta and its receptors in gastric carcinoma tissue
T Kai1, F Taketazu, M Kawakami
1Department of Surgery, Omiya Medical Center, Jichi Medical School, Saitama.
Abstract:
The distribution of the three mammalian isoforms of transforming growth factor (TGF)-beta (TGF-beta 1, -beta 2, and -beta 3) as well as their signaling receptors, TGF-beta type I and type II receptors (T beta R-I and T beta R-II, respectively), in gastric carcinoma tissue was examined by immunohistochemistry using specific antibodies. Tissue specimens were obtained from 25 cases of gastric carcinoma, which were classified into two groups according to Lauren's classification, i.e. 15 cases of diffuse carcinoma and 10 cases of intestinal carcinoma. In normal gastric mucosa apart from carcinoma nests, all of TGF-beta 1, -beta 2, -beta 3, T beta R-I and T beta R-II were clearly demonstrated in fundic glands. In sharp contrast, none of them was detectable in surface mucous cells. In carcinoma cells, strong staining for TGF-beta 1, -beta 2 and -beta 3 was obtained only in diffuse-type carcinoma. In particular, carcinoma cells scattered as single cells or small nests had a tendency to show strong staining for TGF-betas. The receptors tended to be distributed concomitantly with the ligands, and diffuse-type carcinoma showed stronger receptor staining than intestinal-type carcinoma. In cancer stroma, TGF-betas and receptors were detected in both diffuse and intestinal types, but the area with positive staining was wider and more dispersed in diffuse-type carcinoma than in intestinal carcinoma. These results suggest that TGF-beta may contribute in part to the variety of histogenesis and mode of progression of gastric carcinoma.
Insights
Transforming growth factor-beta (TGF-β) and its receptors are present in normal gastric mucosa but absent in surface cells. TGF-β is strongly expressed in diffuse-type gastric carcinoma, suggesting its role in cancer progression.
Area of Science:
- Gastroenterology
- Oncology
- Molecular Biology
Background:
- Transforming growth factor-beta (TGF-β) is a crucial cytokine involved in cell growth, differentiation, and apoptosis.
- Gastric carcinoma, a significant global health concern, exhibits diverse histological subtypes with varying prognoses.
Purpose of the Study:
- To investigate the distribution of TGF-β isoforms (1, 2, and 3) and their signaling receptors (TβR-I and TβR-II) in gastric carcinoma.
- To correlate the expression patterns with Lauren's classification (diffuse vs. intestinal type) and potential roles in tumorigenesis.
Main Methods:
- Immunohistochemistry was employed to detect TGF-β isoforms and their receptors in 25 gastric carcinoma tissue specimens.
- Specimens were categorized into diffuse (15 cases) and intestinal (10 cases) types based on Lauren's classification.
Main Results:
- TGF-β isoforms and receptors were detected in normal gastric fundic glands but not in surface mucous cells.
- Strong TGF-β expression was observed in carcinoma cells of diffuse-type gastric carcinoma, particularly in scattered single cells or small nests.
- Receptor distribution paralleled ligand expression, with diffuse-type carcinoma showing stronger receptor staining than intestinal-type.
- TGF-βs and receptors were present in the stroma of both types, but more widespread in diffuse-type carcinoma.
Conclusions:
- TGF-β signaling is dysregulated in gastric carcinoma, with distinct patterns observed between diffuse and intestinal subtypes.
- The expression of TGF-β and its receptors suggests a potential role in the histogenesis and progression of gastric carcinoma, particularly the diffuse type.